P-GLYCOPROTEIN AND MULTIDRUG RESISTANCE: STRUCTURE-ACTIVITY RELATIONSHIPS OF MODULATORS

被引：17

作者：

Huber, Paula C. ^{[1
]}

Maruiama, Cintia H. ^{[1
]}

Almeida, Wanda P. ^{[1
]}

机构：

[1] Univ Estadual Campinas, Inst Quim, Dept Quim Organ, BR-13084971 Campinas, SP, Brazil

来源：

QUIMICA NOVA | 2010年 / 33卷 / 10期

关键词：

P-glycoprotein; multidrug resistance; modulators; DRUG-RESISTANCE; ABC TRANSPORTER; CELLS; INHIBITORS; BINDING; MODEL; MDR; COMBINATION; MECHANISMS; TARIQUIDAR;

D O I：

10.1590/S0100-40422010001000027

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

P-GLYCOPROTEIN AND MULTIDRUG RESISTANCE: STRUCTURE-ACTIVITY RELATIONSHIPS OF MODULATORS. Multidrug resistance, MDR is a major obstacle for cancer chemotherapy. MDR can be reversed by drugs that vary in their chemical structure and main biological activity. Many efforts have been done to overcome MDR based on studies of structure-activity relationships and in this review we summarize some aspects of MDR mediated by P-glycoprotein (P-gp), as the most experimentally and clinically tested form of drug resistance. The most significant MDR mechanisms revealed until now are shortly discussed. Physicochemical and structural properties of MDR modulators, measures of the MDR reversal, and QSAR studies are included.

引用

页码：2148 / 2154

页数：7

共 82 条

[1] Trimers of N-alkylglycines are potent modulators of the multidrug resistance phenotype [J].

Abad-Merin, MJ ;

Cortés, N ;

Masip, I ;

Pérez-Payá, E ;

Ferragut, JA ;

Messeguer, A ;

Ferrer-Montiel, A .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (01) :112-120

[2] Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding [J].

Aller, Stephen G. ;

Yu, Jodie ;

Ward, Andrew ;

Weng, Yue ;

Chittaboina, Srinivas ;

Zhuo, Rupeng ;

Harrell, Patina M. ;

Trinh, Yenphuong T. ;

Zhang, Qinghai ;

Urbatsch, Ina L. ;

Chang, Geoffrey .

SCIENCE, 2009, 323 (5922) :1718-1722

[3] MECHANISMS OF MULTIDRUG RESISTANCE IN HUMAN TUMOR-CELLS - THE ROLES OF P-GLYCOPROTEIN, DNA TOPOISOMERASE-II, AND OTHER FACTORS [J].

BECK, WT .

CANCER TREATMENT REVIEWS, 1990, 17 :11-20

[4]

BIEDLER JL, 1970, CANCER RES, V30, P1174

[5] New potent P-glycoprotein inhibitors carrying a polycyclic scaffold [J].

Bisi, Alessandra ;

Gobbi, Silvia ;

Rampa, Angela ;

Belluti, Federica ;

Piazzi, Lorna ;

Valenti, Piero ;

Gyemant, Nora ;

Molnar, Joseph .

JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (11) :3049-3051

[6] Quercetin as a Potential Modulator of P-Glycoprotein Expression and Function in Cells of Human Pancreatic Carcinoma Line Resistant to Daunorubicin [J].

Borska, Sylwia ;

Sopel, Miroslaw ;

Chmielewska, Magdalena ;

Zabel, Maciej ;

Dziegiel, Piotr .

MOLECULES, 2010, 15 (02) :857-870

[7] A family of drug transporters: The multidrug resistance-associated proteins [J].

Borst, P ;

Evers, R ;

Kool, M ;

Wijnholds, J .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1295-1302

[8] Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux [J].

Chavanpatil, Mahesh D. ;

Khdair, Ayman ;

Gerard, Brigitte ;

Bachmeier, Corbin ;

Miller, Donald W. ;

Shekhar, Malathy P. V. ;

Panyam, Jayanth .

MOLECULAR PHARMACEUTICS, 2007, 4 (05) :730-738

[9] Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux [J].

Chavanpatil, Mahesh D. ;

Patil, Yogesh ;

Panyam, Jayanth .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 320 (1-2) :150-156

[10] Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives [J].

Colabufo, Nicola Antonio ;

Berardi, Francesco ;

Cantore, Mariangela ;

Perrone, Maria Grazia ;

Contino, Marialessandra ;

Inglese, Carmela ;

Niso, Mauro ;

Perrone, Roberto ;

Azzariti, Amalia ;

Simone, Grazia Maria ;

Porcelli, Letizia ;

Paradiso, Angelo .

BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (01) :362-373

← 1 2 3 4 5 6 7 8 9 →